Role of S100A12 in the pathogenesis of osteoarthritis

Biochemical and Biophysical Research Communications

Volumn 422, Issue 3, 2012, Pages 508-514

  Nakashima, Motoshige ^a   Sakai, Tadahiro ^a   Hiraiwa, Hideki ^a   Hamada, Takashi ^a   Omachi, Takaaki ^a   Ono, Yohei ^a,b   Inukai, Norio ^c   Ishizuka, Shinya ^a   Matsukawa, Tetsuya ^a   Oda, Tomoyuki ^a   Takamatsu, Akira ^a   Yamashita, Satoshi ^a   Ishiguro, Naoki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EAST CAROLINA UNIVERSITY   (United States)

^c Nishio Municipal Hospital   (Japan)

Author keywords

Chondrocytes; Matrix metalloproteinase 13; Osteoarthritis; Receptor for advanced glycation end products; S100A12; Vascular endothelial growth factor

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; COLLAGENASE 3; I KAPPA B; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PROTEIN S 100; PROTEIN S100A12; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KNEE OSTEOARTHRITIS; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; HUMANS; MATRIX METALLOPROTEINASE 13; NF-KAPPA B; OSTEOARTHRITIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; S100 PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84861952489     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.036     Document Type: Article

References (33)

1. Altman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria committee of the American rheumatism association. Arthritis and Rheumatism 1986, 29:1039-1049.
2. Sandell L.J., Aigner T. Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis Research 2001, 3:107-113.
3. Poole A.R., Nelson F., Dahlberg L., Tchetina E., Kobayashi M., Yasuda T., et al. Proteolysis of the collagen fibril in osteoarthritis. Biochemical Society Symposium 2003, 70:115-123.
4. Ortega N., Behonick D.J., Werb Z. Matrix remodeling during endochondral ossification. Trends in Cell Biology 2004, 14:86-93.
5. Reboul P., Pelletier J.P., Tardif G., Cloutier J.M., Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. Journal of Clinical Investigation 1996, 97:2011-2019.
6. Bondeson J., Blom A.B., Wainwright S., Hughes C., Caterson B., van den Berg W.B. The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis and Rheumatism 2010, 62:647-657.
7. Saito T., Fukai A., Mabuchi A., Ikeda T., Yano F., Ohba S., et al. Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development. Nature Medicine 2010, 16:678-686.
8. Zelzer E., Mamluk R., Ferrara N., Johnson R.S., Schipani E., Olsen B.R. VEGFA is necessary for chondrocyte survival during bone development. Development (Cambridge, England) 2004, 131:2161-2171.
9. Schenk R.K., Spiro D., Wiener J. Cartilage resorption in the tibial epiphyseal plate of growing rats. Journal of Cell Biology 1967, 34:275-291.
10. Tamiya H., Ikeda T., Jeong J.-H., Saito T., Yano F., Jung Y.-K., et al. Analysis of the Runx2 promoter in osseous and non-osseous cells and identification of HIF2A as a potent transcription activator. Gene 2008, 416:53-60.
11. Enomoto H., Inoki I., Komiya K., Shiomi T., Ikeda E., Obata K.-ichi, et al. Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. American Journal of Pathology 2003, 162:171-181.
12. Kamekura S., Kawasaki Y., Hoshi K., Shimoaka T., Chikuda H., Maruyama Z., et al. Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis and Rheumatism 2006, 54:2462-2470.
13. Pietzsch J., Hoppmann S. Human S100A12: a novel key player in inflammation?. Amino Acids 2009, 36:381-389.
14. Lagasse E., Weissman I.L. Mouse MRP8 and MRP14, two intracellular calcium-binding proteins associated with the development of the myeloid lineage. Blood 1992, 79:1907-1915.
15. Renaud W., Merten M., Figarella C. Increased coexpression of CFTR and S100 calcium binding proteins MRP8 and MRP14 mRNAs in cystic fibrosis human tracheal gland cells. Biochemical and Biophysical Research Communications 1994, 201:1518-1525.
16. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97:889-901.
17. Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. Journal of Clinical Investigation 2001, 108:949-955.
18. van Lent P.L.E.M., Grevers L.C., Blom A.B., Arntz O.J., van de Loo F.A., van der Kraan P., et al. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis. Arthritis and Rheumatism 2008, 58:3776-3787.
19. Schelbergen R.F.P., Blom A.B., van den Bosch M.H.J., Slöetjes A., Abdollahi-Roodsaz S., Schreurs B.W., et al. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on toll-like receptor 4. Arthritis and Rheumatism 2012, 64:1477-1487.
20. Yammani R.R., Carlson C.S., Bresnick A.R., Loeser R.F. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: Role of the receptor for advanced glycation end products. Arthritis and Rheumatism 2006, 54:2901-2911.
21. Cecil D.L., Johnson K., Rediske J., Lotz M., Schmidt A.M., Terkeltaub R. Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products. Journal of Immunology 2005, 175:8296-8302.
22. Cecil D.L., Terkeltaub R. Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes. Journal of Immunology 2008, 180:8378-8385.
23. Baillet A., Trocmé C., Berthier S., Arlotto M., Grange L., Chenau J., et al. Synovial fluid proteomic fingerprint: S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases. Rheumatology (Oxford, England) 2010, 49:671-682.
24. Boussac M., Garin J. Calcium-dependent secretion in human neutrophils: a proteomic approach. Electrophoresis 2000, 21:665-672.
25. Foell D., Kucharzik T., Kraft M., Vogl T., Sorg C., Domschke W., et al. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 2003, 52:847-853.
26. Guignard F., Mauel J., Markert M. Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochemical Journal 1995, 309(Pt 2):395-401.
27. Smith M.D., Triantafillou S., Parker A., Youssef P.P., Coleman M. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. Journal of Rheumatology 1997, 24:365-371.
28. Benito M.J., Veale D.J., FitzGerald O., van den Berg W.B., Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis. Annals of the Rheumatic Diseases 2005, 64:1263-1267.
29. Foell D., Kane D., Bresnihan B., Vogl T., Nacken W., Sorg C., et al. Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford, England) 2003, 42:1383-1389.
30. Myles A., Viswanath V., Singh Y.P., Aggarwal A. Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA Category) and inversely correlates with disease activity and S100A12 levels. Journal of Rheumatology 2011, 38:1994-1999.
31. Rouleau P. The calcium-binding protein S100A12 induces neutrophil adhesion, migration, and release from bone marrow in mouse at concentrations similar to those found in human inflammatory arthritis. Clinical Immunology 2003, 107:46-54.
32. van den Berg W.B. Osteoarthritis year 2010 in review: pathomechanisms, osteoarthritis and cartilage/OARS. Osteoarthritis Research Society 2011, 19:338-341.
33. Loeser R.F., Yammani R.R., Carlson C.S., Chen H., Cole A., et al. Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis. Arthritis and Rheumatism 2005, 52:2376-2385.